Skip to content

Ultrasound-Guided Popliteal sciatic Nerve Block with Short-Acting 1.5% Ligocaine in the lower limb surgeries

COMPARING LOW VOLUME 1.5% LIGNOCAINE VS CONVENTIONAL VOLUME 1.5% LIGNOCAINE IN ULTRASOUND GUIDED POPLITEAL SCIATIC NERVE BLOCK - A NON INFERIORITY TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050091
Enrollment
40
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 3- Administration Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Ultrasound guided popliteal sciatic nerve block: The procedure will be performed with the patient in lateral position and the popliteal fossa will be sterilized using 2.5 %Chlorhexidine

Sponsors

Dr Merlin shalini ruth
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients aged between 18 and 80 years ASA- II & III physical status Patients undergoing diabetic foot surgeries

Exclusion criteria

Exclusion criteria: Allergy to local anesthetics Blood coagulopathy Neuromuscular disease Moderate and severe Neuropathy according to Toronto clinical scoring system (9+)

Design outcomes

Secondary

MeasureTime frame
To compare onset time of sensory and motor block To compare duration of motor block To compare patient satisfaction Timepoint: Baseline 30 minutes after procedure

Primary

MeasureTime frame
To compare the duration of sensory block of low vs conventional 1.5% lignocaine with adrenaline in ultrasound guided popliteal sciatic nerve block Timepoint: Baseline from 30seconds of drug administration

Countries

India

Contacts

Public ContactDr Manoj S

Chettinad hospital and research institute

merlin5shalini@gmail.com8508996140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026